HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

China Resources Related

964.849

-1.082-0.11%

Number of Gainers:4

Number of Losers:3

Number of Flat:- -

PE:- -

High:969.847

Open:965.312

Low:959.227

Close:965.931

Volume:70.19M

Turnover:1.13B

Market Cap:504.88B

Float Cap:504.88B

Loading ...

CR BLDG MAT TEC Announces Li Nan's Appointment to Nomination Committee

Dong-E-E-Jiao Co.,Ltd., a CHINARES PHARMA Subsidiary, Plans Health Consumer Goods Industrial Park

China Resources Building Materials Files Director List to HKEX

China Resources Building Materials Appoints Li Nan to Nomination Committee as Zhu Ping Retires

China Resources Building Materials Technology Holdings Ltd. meldet Wechsel im Aufsichtsrat und im Nominierungsausschuss

China Resources Pharmaceutical investiert rund 1,4 Milliarden RMB in neues Gesundheitsindustriepark-Projekt

China Resources Pharmaceutical Group Ltd - Investment in and Construction of Health Consumer Products Industrial Park

THOMSON REUTERS

BRIEF-China Resources Pharmaceutical Announces Potential Disposal Of Tianmai Biotechnology

CHINARES PHARMA Considers Divesting Approximately 17.87% Stake in Tianmai Biotech

China Resources Pharmaceutical Group Seeks to Sell 17.87% Stake in Tianmai Biotechnology

China Resources Pharmaceutical - Disposal Through Public Tender Process on Shanghai United Assets and Equity Exchange

THOMSON REUTERS

China Resources Pharmaceutical - Unit Initiated Potential Disposal of 17.87% Stake in Hefei Tianmai Biotechnology Development

THOMSON REUTERS

China Resources Pharmaceutical Group Ltd - a Minimum Listing Price of Approximately RMB1.42 Bln

THOMSON REUTERS

China Resources Pharmaceutical Group Ltd - Potential Disposal of Tianmai Biotechnology

THOMSON REUTERS

BRIEF-Fitch Says Agency Affirms Ratings On 5 Chinese Homebuilders Following Criteria Updates

Tasly Pharmaceutical's Profit Rises 16% in 2025

MT Newswires Live

Property Market Stability Holds Significant Influence on Market Trends

Private companies among China Resources Beer (Holdings) Company Limited's (HKG:291) largest shareholders, saw gain in holdings value after stock jumped 3.8% last week

Simply Wall St.

China Resources Pharmaceutical Group Ltd. hielt außerordentliche Hauptversammlung ab

BRIEF-China Resources Pharmaceutical Updates On KPC Pharmaceuticals

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK1570/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1570","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1570\",,,,,undefined,":{"symbol":"BK1570","market":"HK","secType":"PLATE","nameCN":"China Resources Related","latestPrice":964.84894,"timestamp":1770710952494,"preClose":965.931,"halted":0,"volume":70193965,"delay":0,"changeRate":-0.00112,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Closed","change":-1.082092,"latestTime":"02-10 16:00:00","open":965.3117,"high":969.84656,"low":959.22687,"amount":1131065745,"amplitude":0.010994,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770773400000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1770687000000,1770696000000],[1770699600000,1770710400000]],"pbRate":0.802574,"peRate":8.839749,"turnoverRate":0.002018,"increases":4,"decrements":3,"flats":0,"marketCap":504884583424,"floatMarketCap":504880216064},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1570\",,,,,undefined,":{"symbol":"BK1570","high":969.84656,"amplitude":0.010994,"preClose":965.931,"low":959.22687,"pbRate":"0.802574","latestPrice":964.84894,"volume":70193965,"delay":0,"open":965.3117,"prevYearClose":885.673,"prevWeekClose":956.845,"prevMonthClose":936.351,"prevQuarterClose":885.673,"fiveDayClose":927.731,"twentyDayClose":921.355,"sixtyDayClose":978.707,"secType":"PLATE","market":"HK","turnoverRate":0.002018,"peRate":8.839749,"marketCap":504884583424,"floatMarketCap":504880216064,"timestamp":1770710952494,"nameCN":"China Resources Related"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1570\",,,,undefined,":{"bkCode":"BK1570","up":4,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1570\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1124827141","title":"CR BLDG MAT TEC Announces Li Nan's Appointment to Nomination Committee","url":"https://stock-news.laohu8.com/highlight/detail?id=1124827141","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1124827141?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:14","pubTimestamp":1770718494,"startTime":"0","endTime":"0","summary":"CR BLDG MAT TEC (01313) announced that Mr. Zhu Ping has informed the board of his retirement plan and will step down as a non-executive director and a member of the board's nomination committee,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1589","BK1594","LU0274383008.USD","SG9999003461.SGD","BK1570","01313","SG9999002950.SGD","BK1135","BK1563","BK1507"],"gpt_icon":0},{"id":"1150601432","title":"Dong-E-E-Jiao Co.,Ltd., a CHINARES PHARMA Subsidiary, Plans Health Consumer Goods Industrial Park","url":"https://stock-news.laohu8.com/highlight/detail?id=1150601432","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150601432?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:14","pubTimestamp":1770718491,"startTime":"0","endTime":"0","summary":"CHINARES PHARMA has announced that its non-wholly owned subsidiary, Dong-E-E-Jiao Co.,Ltd., has resolved to invest in and construct a health consumer goods industrial park. The park is expected to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0175","BK1570","03320","BK0196","BK0187","BK0183","BK0188","BK0028","BK0239","BK1191","BK0010","SG9999014674.SGD","000423"],"gpt_icon":0},{"id":"2610564569","title":"China Resources Building Materials Files Director List to HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2610564569","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610564569?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:10","pubTimestamp":1770718242,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Building Materials Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL2tJBmz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1507","01313","BK1570","BK1563","BK1594","LU0274383008.USD","BK1135","BK1589","SG9999002950.SGD","SG9999003461.SGD"],"gpt_icon":0},{"id":"2610645558","title":"China Resources Building Materials Appoints Li Nan to Nomination Committee as Zhu Ping Retires","url":"https://stock-news.laohu8.com/highlight/detail?id=2610645558","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610645558?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:08","pubTimestamp":1770718122,"startTime":"0","endTime":"0","summary":"China Resources Building Materials Technology Holdings Ltd. announced that Mr. Zhu Ping has retired as a non-executive director and member of the nomination committee, effective 10 February 2026. Mr. Li Nan, a non-executive director, has been appointed as a member of the nomination committee on the same date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Building Materials Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 10, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL5j7VjL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999003461.SGD","SG9999002950.SGD","BK1589","BK1563","01313","BK1507","BK1570","BK1594","LU0274383008.USD","BK1135"],"gpt_icon":0},{"id":"2610645553","title":"China Resources Building Materials Technology Holdings Ltd. meldet Wechsel im Aufsichtsrat und im Nominierungsausschuss","url":"https://stock-news.laohu8.com/highlight/detail?id=2610645553","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610645553?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:08","pubTimestamp":1770718122,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Building Materials Technology Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL2MT89H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1135","BK1594","LU0274383008.USD","SG9999003461.SGD","BK1570","01313","BK1563","SG9999002950.SGD","BK1589","BK1507"],"gpt_icon":0},{"id":"2610584645","title":"China Resources Pharmaceutical investiert rund 1,4 Milliarden RMB in neues Gesundheitsindustriepark-Projekt","url":"https://stock-news.laohu8.com/highlight/detail?id=2610584645","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610584645?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:07","pubTimestamp":1770718020,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 10, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nNDL3fRwdx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","BK0239","BK1570","BK0196","BK0187","BK1191","BK0028","000423","BK0188","BK0175","SG9999014674.SGD","BK0183","BK0010"],"gpt_icon":0},{"id":"2610645585","title":"China Resources Pharmaceutical Group Ltd - Investment in and Construction of Health Consumer Products Industrial Park","url":"https://stock-news.laohu8.com/highlight/detail?id=2610645585","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610645585?lang=en_us&edition=fundamental","pubTime":"2026-02-10 18:06","pubTimestamp":1770718014,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260210:nFWN3Z60MJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03320","BK1191","BK1570"],"gpt_icon":0},{"id":"2610591646","title":"BRIEF-China Resources Pharmaceutical Announces Potential Disposal Of Tianmai Biotechnology","url":"https://stock-news.laohu8.com/highlight/detail?id=2610591646","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610591646?lang=en_us&edition=fundamental","pubTime":"2026-02-09 22:41","pubTimestamp":1770648076,"startTime":"0","endTime":"0","summary":"BRIEF-China Resources Pharmaceutical Announces Potential Disposal Of Tianmai BiotechnologyFeb 9 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:POTENTIAL DISPOSAL OF TIANMAI BIOTECHNOLOGY","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"1171755274","title":"CHINARES PHARMA Considers Divesting Approximately 17.87% Stake in Tianmai Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=1171755274","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171755274?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:50","pubTimestamp":1770637814,"startTime":"0","endTime":"0","summary":"CHINARES PHARMA (03320) has announced that its wholly-owned subsidiary, China Resources Pharmaceutical Investment Co., Ltd., has initiated a potential sale of approximately 17.87% of its stake in...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1570","BK4585","LABU","BK4588","03320","159837"],"gpt_icon":0},{"id":"2610329876","title":"China Resources Pharmaceutical Group Seeks to Sell 17.87% Stake in Tianmai Biotechnology","url":"https://stock-news.laohu8.com/highlight/detail?id=2610329876","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610329876?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:44","pubTimestamp":1770637485,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Investment Company Limited, a wholly-owned subsidiary of China Resources Pharmaceutical Group Ltd., has initiated a potential disposal of approximately 17.87% equity interests in Hefei Tianmai Biotechnology Development Co., Ltd. through a public tender process on the Shanghai United Assets and Equity Exchange. The minimum listing price for the stake is set at around RMB 1.42 billion. As of the announcement date, no intended transferee has been identified and no transaction agreements have been signed. The process will lapse if no suitable transferee is found.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news b","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nNDL3TcjmP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"China Resources Pharmaceutical Group Seeks to Sell 17.87% Stake in Tianmai Biotechnology","news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2610632925","title":"China Resources Pharmaceutical -  Disposal Through Public Tender Process on Shanghai United Assets and Equity Exchange","url":"https://stock-news.laohu8.com/highlight/detail?id=2610632925","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610632925?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:44","pubTimestamp":1770637478,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50PK:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2610632921","title":"China Resources Pharmaceutical - Unit Initiated Potential Disposal of 17.87% Stake in Hefei Tianmai Biotechnology Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2610632921","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610632921?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:44","pubTimestamp":1770637478,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50PK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2610629632","title":"China Resources Pharmaceutical Group Ltd - a Minimum Listing Price of Approximately RMB1.42 Bln","url":"https://stock-news.laohu8.com/highlight/detail?id=2610629632","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610629632?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:44","pubTimestamp":1770637478,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50PK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2610326276","title":"China Resources Pharmaceutical Group Ltd - Potential Disposal of Tianmai Biotechnology","url":"https://stock-news.laohu8.com/highlight/detail?id=2610326276","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610326276?lang=en_us&edition=fundamental","pubTime":"2026-02-09 19:44","pubTimestamp":1770637478,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2610638844","title":"BRIEF-Fitch Says Agency Affirms Ratings On 5 Chinese Homebuilders Following Criteria Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2610638844","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610638844?lang=en_us&edition=fundamental","pubTime":"2026-02-09 16:48","pubTimestamp":1770626885,"startTime":"0","endTime":"0","summary":"BRIEF-Fitch Says Agency Affirms Ratings On 5 Chinese Homebuilders Following Criteria UpdatesFeb 9 (Reuters) - FITCH AFFIRMS RATINGS ON FIVE CHINESE HOMEBUILDERS FOLLOWING CRITERIA UPDATESSource text: ID:nFIT70X5KN ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260209:nFWN3Z50E8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0501845795.SGD","LU0594300179.USD","LU1993786604.SGD","BK1240","LU3063872942.SGD","LU0348825331.USD","LU1152091754.HKD","LU0417516902.SGD","LU0516422952.EUR","SG9999010078.USD","LU0791591158.USD","600376","LU0048580855.USD","LU0791590937.USD","LU1023057109.AUD","HK0000306701.USD","LU0048597586.USD","LU1242518857.USD","BK1521","LU1242518931.SGD","LU1171460220.USD","LU2088748376.SGD","LU0359202008.SGD","LU1807302812.USD","LU0072913022.USD","BK1589","LU0605514214.HKD","LU1880383366.USD","LU2088747725.USD","LU1008478684.HKD","BK0028","BK1570","LU0738912210.USD","LU0251144936.SGD","LU0979878070.USD","IE0008368742.USD","LU1366334651.USD","BK0188","LU0516422440.USD","00123","LU0516423091.SGD","LU1366334578.USD","LU0287142896.SGD","00960","LU0414403682.SGD","LU0516423174.USD","01109","HK0000320223.HKD","SG9999014674.SGD","BK0172"],"gpt_icon":0},{"id":"2610862688","title":"Tasly Pharmaceutical's Profit Rises 16% in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2610862688","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610862688?lang=en_us&edition=fundamental","pubTime":"2026-02-09 12:14","pubTimestamp":1770610495,"startTime":"0","endTime":"0","summary":"Tasly Pharmaceutical , a unit of China Resources Pharmaceutical , posted net profit attributable to shareholders of 1.11 billion yuan for 2025, up 15.7% from 955.6 million yuan a year earlier, according to a Feb. 6 Hong Kong bourse filing.Basic earnings per share came in at 0.74 yuan from 0.64 yuan in the prior year.Operating revenue slipped 3% to 8.24 billion yuan from 8.50 billion yuan, the filing showed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1570","BK1191","BK0188","BK0183","BK0028","03320","600535","BK0196","BK0239","BK0012"],"gpt_icon":0},{"id":"1132582105","title":"Property Market Stability Holds Significant Influence on Market Trends","url":"https://stock-news.laohu8.com/highlight/detail?id=1132582105","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132582105?lang=en_us&edition=fundamental","pubTime":"2026-02-09 09:20","pubTimestamp":1770600019,"startTime":"0","endTime":"0","summary":"Last week's market performance was indeed unfavorable, with weakness observed in assets like gold and Bitcoin, alongside growing skepticism towards technology stocks. The Hang Seng Index fell below...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0149721374.USD","00817","LU1770036033.HKD","SGXZ86797644.SGD","HK0000320264.USD","LU1152091168.USD","LU0173614495.USD","BK1224","LU0880133367.SGD","LU1960683339.HKD","LU2543165471.USD","SG9999001069.SGD","BK1240","LGFRY","LU0417516902.SGD","LU0359201612.USD","LU0501845795.SGD","LU2088748020.USD","LU1807302812.USD","LU0594300179.USD","LU0345776255.USD","LU0605514214.HKD","LU0287142896.SGD","LU0611395673.USD","LU0516422440.USD","513600","LU0516422952.EUR","LU0531971595.HKD","BEKE","SG9999010078.USD","HK0000306685.HKD","LU0211977185.USD","LU1242518931.SGD","LU0327786744.USD","LU2088747725.USD","SG9999014674.SGD","SG9999002950.SGD","LU0738912210.USD","BK1570","02423","LU0979878070.USD","LU0516422366.SGD","LU1008478684.HKD","HK0000306701.USD","LU0345775950.USD","BK1521","LU0791591158.USD","LU2088748376.SGD","BK1589","SG9999009997.SGD","LU0823426308.USD","HSImain","LU0572944931.SGD","LU0359201885.HKD","LU1366334651.USD","01109","CRBJY","LU0823426480.USD","00960","LU0067412154.USD","LU0516423174.USD","LU0650527681.SGD","LU1880383366.USD","LU1993786604.SGD","IE0008368742.USD","HK0000320223.HKD","FRSHY","LU1366334578.USD","LU0164865239.USD","LU0348825331.USD","LU1152091754.HKD","LU0039217434.USD","MCHmain","LU3063872942.SGD","LU0048597586.USD","LU1023057109.AUD","LU0048580855.USD","LU0593848301.USD","LU0231483743.USD","LU0307460666.USD","LU0791590937.USD","02833","LU0871576103.HKD","LU1481107354.HKD","HHImain","BK1555","LU0588546209.SGD","LU0414403682.SGD","LU1242518857.USD","LU0499858602.USD","LU2088748293.HKD","IE0034224299.USD","SG9999010052.SGD","LU0164880469.USD","LU0516423091.SGD","LU0594300419.USD","LU2088747998.USD","LU0370786039.SGD","LU0499858438.USD","LU0359202008.SGD","LU0251144936.SGD","LU0348767384.USD","SGXZ62798434.SGD","LU0072913022.USD","LU0348766576.USD"],"gpt_icon":0},{"id":"2610502985","title":"Private companies among China Resources Beer (Holdings) Company Limited's (HKG:291) largest shareholders, saw gain in holdings value after stock jumped 3.8% last week","url":"https://stock-news.laohu8.com/highlight/detail?id=2610502985","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610502985?lang=en_us&edition=fundamental","pubTime":"2026-02-09 08:03","pubTimestamp":1770595408,"startTime":"0","endTime":"0","summary":"Key Insights The considerable ownership by private companies in China Resources Beer (Holdings) indicates that they...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/5111000-choice2-main-header/1585186902639","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/5111000-choice2-main-header/1585186902639"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/food-beverage-tobacco/hkg-291/china-resources-beer-holdings-shares/news/private-companies-among-china-resources-beer-holdings-compan-2","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/food-beverage-tobacco/hkg-291/china-resources-beer-holdings-shares/news/private-companies-among-china-resources-beer-holdings-compan-2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1328615791.USD","BK1570","LU0359201612.USD","IE0031814852.USD","LU0359202008.SGD","00291","BK1583","IE00B29SXG58.USD","BK1521","SG9999006514.SGD","IE00B031HY20.USD","BK1578","80291","BK1604","IE0008368742.USD","LU1769817179.HKD","IE0008369823.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","LU1769817096.USD","BK1180","BK1589","CRHKY","IE00B0169L03.USD","IE00B543WZ88.USD","LU1794554557.SGD","LU1720050803.USD","BK1510","LU1023057109.AUD","LU0328353924.USD"],"gpt_icon":0},{"id":"2609591236","title":"China Resources Pharmaceutical Group Ltd. hielt außerordentliche Hauptversammlung ab","url":"https://stock-news.laohu8.com/highlight/detail?id=2609591236","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609591236?lang=en_us&edition=fundamental","pubTime":"2026-02-06 22:19","pubTimestamp":1770387580,"startTime":"0","endTime":"0","summary":"China Resources Pharmaceutical Group Ltd. hat am 6. Februar 2026 eine auerordentliche Hauptversammlung abgehalten. Die vorgeschlagenen Punkte – die Genehmigung fortlaufender verbundener Transaktionen im Rahmen des Sales Framework Agreement 2026/2028 sowie die nderungen der Satzung – wurden jeweils angenommen.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on February 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL6dLYqM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2609599250","title":"BRIEF-China Resources Pharmaceutical Updates On KPC Pharmaceuticals","url":"https://stock-news.laohu8.com/highlight/detail?id=2609599250","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609599250?lang=en_us&edition=fundamental","pubTime":"2026-02-06 21:58","pubTimestamp":1770386332,"startTime":"0","endTime":"0","summary":"BRIEF-China Resources Pharmaceutical Updates On KPC PharmaceuticalsFeb 6 (Reuters) - China Resources Pharmaceutical Group Ltd 3320.HK:FY PRELIM NET PROFIT ATTRIBUTABLE FOR KPC PHARMACEUTICALS RMB349.9 MILLIONFurther company coverage: 3320.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nFWN3Z20L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0028","600422","BK0188","BK1191","03320","BK1570","BK0060","BK0239"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":72,"code":"91000000","status":"200"}]}}